SKI Market

A+| A| A-|

Indian Indices

Sensex

75,527.95 1,695.40
( 2.30%)

Global Indices

Nasdaq

51,233.54 363.79
(0.72%)

Dow Jones

7,453.14 37.84
(0.51%)

Hang Seng

66,063.56 1,846.29
(2.88%)

Nikkei 225

10,460.24 156.36
(1.52%)

Forex

USD-INR

95.49 0.16
(0.17%)

EUR-INR

110.25 0.17
(0.15%)

GBP-INR

127.74 0.15
(0.12%)

JPY-INR

0.60 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Hester Biosciences Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524669

INE782E01017

452.7953188

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HESTERBIO

35.58

1667.69

EPS(TTM)

Face Value()

Div & Yield %

55.1

0.56

Back

Kotak Mahindra Bank receives RBI approval to acquire up to 9.99% stake in AU Small Finance Bank

May 07,2026

AU Small Finance Bank (AU SFB) has received RBI's letter dated 06 May 2026 according its approval to Kotak Mahindra Bank (KMBL) (along with its subsidiaries, the funds/schemes managed by KMBL's subsidiaries, collective referred as Kotak Mahindra Group) to acquire ‘aggregate holding' of up to 9.99% of the paid-up share capital or voting rights in AU SFB.

75,527.95 1,695.40 ( 2.30%)

51,233.54 363.79 (0.72%)

7,453.14 37.84 (0.51%)

66,063.56 1,846.29 (2.88%)

10,460.24 156.36 (1.52%)

95.49 0.16 (0.17%)

110.25 0.17 (0.15%)

127.74 0.15 (0.12%)

0.60 0.00 (0.21%)